US FDA proposes restrictions on marketing of IVDs for research/investigation-use only
This article was originally published in Clinica
The US Food and Drug Administration has issued draft guidance to clarify how manufacturers should or should not market in vitro diagnostic products that are labelled as "for research use only" (RUO) or "for investigation use only" (IUO).
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Sixty-nine guidance documents have been posted on the tracker since its last update.
A UK regulator with the MHRA is concerned that bioanalytical laboratories are not being given enough time to do their job properly by drug companies under pressure to ensure their clinical trials remain on schedule.
The UK regulator is expecting a rise in amendments and deviations to ongoing clinical investigations of medical devices due to the COVID-19 pandemic and has issued advice on how companies should manage these.